Assessment of Treg cells CD4+CD25+ in chronic cirrhotic liver disease and hepatocellular carcinoma Egyptian patients

Hepatitis Monthly

Volumn 8, Issue 3, 2008, Pages 173-177

  El Bassuoni, Maha A ^a   Obada, Mones A ^a   Korah, Tarek ^a   El Sayed, Sawsan ^a  

^a MENOUFIA UNIVERSITY   (Egypt)

Author keywords

CD4+CD25+ Treg cell; HCV; Hepatocellular carcinoma; Liver cirrhosis

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA FETOPROTEIN; ASPARTATE AMINOTRANSFERASE; CD3 ANTIGEN; CD4 ANTIGEN; CD45RA ANTIGEN; FLUORESCEIN ISOTHIOCYANATE; GAMMA GLUTAMYLTRANSFERASE; HEPATITIS B ANTIBODY; HEPATITIS C ANTIBODY; IMMUNOGLOBULIN G; INTERLEUKIN 2 RECEPTOR ALPHA; PHYCOERYTHRIN;

ADULT; ARTICLE; BLOOD SAMPLING; CANCER GRADING; CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOMETRY; EGYPT; ENZYME IMMUNOASSAY; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNOBLOTTING; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LYMPHOCYTE SUBPOPULATION; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; REGULATORY T LYMPHOCYTE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR IMMUNITY;

EID: 56149115388     PISSN: 1735143X     EISSN: 17353408     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Dieckmann D, Plottner H, Berchtold S, Berger T, Schuler G. Ex vivo isolation and characterization of CD4 (+) CD25 (+) T cells with regulatory properties from human blood. J Exp Med 2001; 193: 1303-10.
2. Jonuleit H, Schmitt E, Stassen M, Tuettenberg A, Knop J, Enk AH. Identification and functional characterization of human CD4 (+) CD25 (+) T cells with regulatory properties isolated from peripheral blood. J Exp Med 2001; 193: 1285-94.
3. Ng WF, Duggan PJ, Ponchel F, et al. Human CD4 (+) CD25 (+) cells: a naturally occurring population of regulatory T cells. Blood 2001; 98: 2736-44.
4. Elgert KD, Alleva DG, Mullins DW. Tumor-induced immune dysfunction: the macrophage connection. J Leukoc Biol 1998; 64: 275-90.
5. Staveley-O'Carroll K, Sotomayor E, Montgomery J, et al. Induction of antigen-specific T cell anergy: An early event in the course of tumor progression. Proc Natl Acad Sci U S A 1998; 95: 1178-83.
6. Thornton AM, Shevach EM. Suppressor effector function of CD4+CD25+ immunoregulatory T cells is antigen nonspecific. J Immunol 2000; 164: 183-90.
7. Thornton AM, Shevach EM. CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J Exp Med 1998; 188: 287-96.
8. Miescher S, Whiteside TL, Carrel S, von Fliedner V. Functional properties of tumor-infiltrating and blood lymphocytes in patients with solid tumors: effects of tumor cells and their supernatants on proliferative responses of lymphocytes. J Immunol 1986; 136: 1899-907.
9. Kiessling R, Wasserman K, Horiguchi S, et al. Tumor-induced immune dysfunction. Cancer Immunol Immunother 1999; 48: 353-62.
10. Cao M, Cabrera R, Xu Y, et al. Hepatocellular carcinoma cell supernatants increase expansion and function of CD4 (+) CD25 (+) regulatory T cells. Lab Invest 2007; 87: 582-90.
11. Sakaguchi S, Sakaguchi N, Shimizu J, et al. Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance. Immunol Rev 2001; 182: 18-32.
12. Woo EY, Yeh H, Chu CS, et al. Cutting edge: Regulatory T cells from lung cancer patients directly inhibit autologous T cell proliferation. J Immunol 2002; 168: 4272-6.
13. Liyanage UK, Moore TT, Joo HG, et al. Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma. J Immunol 2002; 169: 2756-61.
14. Frasca L, Carmichael P, Lechler R, Lombardi G. Anergic T cells effect linked suppression. Eur J Immunol 1997; 27: 3191-7.
15. Wolf AM, Wolf D, Steurer M, Gastl G, Gunsilius E, Grubeck-Loebenstein B. Increase of regulatory T cells in the peripheral blood of cancer patients. Clin Cancer Res 2003; 9: 606-12.
16. Ichihara F, Kono K, Takahashi A, Kawaida H, Sugai H, Fujii H. Increased populations of regulatory T cells in peripheral blood and tumor-infiltrating lymphocytes in patients with gastric and esophageal cancers. Clin Cancer Res 2003; 9: 4404-8.
17. Somasundaram R, Jacob L, Swoboda R, et al. Inhibition of cytolytic T lymphocyte proliferation by autologous CD4+/CD25+ regulatory T cells in a colorectal carcinoma patient is mediated by transforming growth factor-beta. Cancer Res 2002; 62: 5267-72.
18. Dannull J, Cerny T, Ackermann DK, Groettrup M. Current Status of Dendritic Cell-Based Tumor Vaccination. Onkologie 2000; 23: 544-551.
19. Kono K, Takahashi A, Ichihara F, et al. Prognostic significance of adoptive immunotherapy with tumor-associated lymphocytes in patients with advanced gastric cancer: a randomized trial. Clin Cancer Res 2002; 8: 1767-71.